In adjusted mixed linear models, weight loss is strongly related to the levels of cancer-associated biologically active substances, including reduced interleukin-6 (IL-6) levels and increased adiponectin levels (Linkov et al., 2012). The gene discussed is ADIPOQ; the disease is cancer.